Information Library
News Items - Phase I/IIa
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
QUINTILES PARTNERS WITH FOUNDATION TRUST & UNIVERSITY TO IMPROVE PATIENT CARE AND DRIVE EFFICIENCY IN CLINICAL RESEARCH
October 26, 2009 - A significant step in driving innovation, improving patient care and increasing efficiency in early stage clinical research was taken today with the announcement that two of the UK’s leading institutions - Guy’s and St Thomas’ NHS Foundation Trust and King’s College London - have signed a collaborative agreement with Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. -
QUINTILES INCREASES CAPACITY TO SUPPORT EUROPEAN CLINICAL TRIALS
September 24, 2009 - Quintiles Transnational Corp. today announced the opening of an expanded regional facility near Edinburgh, Scotland. Located within the Alba Campus, a research and development center near Edinburgh, the 115,000-square-foot building hosts more than 500 employees and has space for Quintiles Clinical Development Services, including Project Management, Regulatory Affairs and Data Management. -
QUINTILES NAMED BEST CLINICAL SERVICE PROVIDER
April 23, 2009 - Quintiles was named by industry decision-makers as the most favored contract research organization (CRO), according to two recently released independent surveys. -
QUINTILES TO OPEN PHASE I UNIT IN INDIA
January 27, 2009 – Quintiles Transnational Corp. announced a partnership with Apollo Hospitals Group to open a Phase I clinical trial unit in Hyderabad, India. -
QUINTILES GDRU RECEIVES PHASE I SUPPLEMENTARY ACCREDITATION
September 10, 2008 - Quintiles Guy’s Drug Research Unit (GDRU) has been awarded supplementary accreditation for Phase I clinical trials, under a new approval programme that has been introduced by the Medicines and Healthcare Regulatory Agency (MHRA).
Page 1 of 1 (5 items)